Previous Close | 2.1400 |
Open | 2.1000 |
Bid | 1.9800 x 0 |
Ask | 1.9900 x 0 |
Day's Range | 1.9700 - 2.1100 |
52 Week Range | 1.5600 - 10.8700 |
Volume | |
Avg. Volume | 2,498,093 |
Market Cap | 589.539M |
Beta (5Y Monthly) | 3.04 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Aurora Cannabis Inc. ("Aurora" or the "Company") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced that it has repurchased an aggregate of approximately $25.3 million (US$20 million) principal amount of its convertible senior notes ("Notes") at a total cost, including accrued interest, of $24.3 million (US$19.2 million) in cash.
Aurora Cannabis Inc. ("Aurora" or the "Company") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, has announced today the closing of its previously announced bought deal offering of units of the Company (the "Units") for gross proceeds of approximately US$172.5 million (the "Offering"). The Company sold approximately 70.4 million Units at a price of US$2.45 per Unit, including approximately 9.2 million Units sold pursuant to the exercise in full of th